Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jul;32(7):2521-2532.
doi: 10.1007/s00586-023-07764-8. Epub 2023 May 20.

Efficacy of perioperative gabapentin use in patients with idiopathic scoliosis undergoing fusion surgery: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Efficacy of perioperative gabapentin use in patients with idiopathic scoliosis undergoing fusion surgery: a systematic review and meta-analysis

Jose Luis Bas et al. Eur Spine J. 2023 Jul.

Abstract

Purpose: This study aimed to assess whether the perioperative use of gabapentin was associated with decreased opioid use.

Methods: A meta-analysis was performed using PubMed, Embase, Scopus, and Cochrane Library. The randomized clinical trials included were focused on patients with adolescent idiopathic scoliosis who underwent posterior fusion surgery and were treated with gabapentin versus placebo medicine. The primary outcomes were opioid consumption at 24, 48, 72, and 96 h; time to introduction of oral medication, length of hospital stay, and period of urinary catheterization were also recorded. Data were combined using the Review Manager 5.4 software.

Results: Four randomized clinical trials with a pool of 196 adolescent patients (mean age: 14.8 ± 2.0 years) were included. At 24 and 48 h after surgery, opioid consumption was significantly lower in the gabapentin group: (standardized mean difference [SMD]: -0.50; 95% confidence interval [CI] - 0.79 to - 0.22) and (SMD: - 0.59; 95% CI - 0.88 to - 0.30), respectively. At 72 and 96 h, there were no significant differences between studies: (SMD: - 0.19; 95% CI - 0.52 to 0.13) and (SMD: 0.12; 95% CI - 0.25 to 0.50), respectively. Regarding the administration type, there were significant differences in favor of the 15 mg/kg subgroup with 600 mg at 48 h (SMD: - 0.69; 95% CI - 1.08 to - 0.30). There were no significant differences concerning the time to introduction of oral medication (MD: - 0.08; 95% CI - 0.39 to 0.23), hospitalization time (MD: - 0.12; 95% CI - 0.40 to 0.16), or period of urinary catheterization (SMD: - 0.27; 95% CI - 0.58 to 0.05).

Conclusions: Gabapentin decreased opioid consumption during the first 48 h. Doses of 15 mg/kg showed superiority in reducing opioid consumption in the first 48 h.

Level of evidence i: Diagnostic: individual cross-sectional studies with consistently applied reference standard and blinding.

Keywords: Adolescent idiopathic scoliosis; Gabapentin; Meta-analysis; Multimodal pain control; Opioid consumption.

PubMed Disclaimer

References

    1. Lee CS, Merchant S, Chidambaran V (2020) Postoperative pain management in pediatric spinal fusion surgery for idiopathic scoliosis. Paediatr Drugs 22(6):575–601. https://doi.org/10.1007/s40272-020-00423-1 - DOI - PubMed
    1. Théroux J, Le May S, Fortin C et al (2015) Prevalence and management of back pain in adolescent idiopathic scoliosis patients: a retrospective study. Pain Res Manag 20(3):153–157. https://doi.org/10.1155/2015/674354 - DOI - PubMed - PMC
    1. Spinal Deformity Study Group, Landman Z, Oswald T, Sanders J et al (2011) Prevalence and predictors of pain in surgical treatment of adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 36:825–829 - DOI
    1. Niraj G, Rowbotham DJ (2011) Persistent postoperative pain: where are we now? J Anaesth 107(1):25–29. https://doi.org/10.1093/bja/aer116 - DOI
    1. Danielsson AJ, Nachemson AL (2003) Back pain and function 23 years after fusion for adolescent idiopathic scoliosis: a case-control study-part II. Spine (Phila Pa 1976) 28(18):E373–E383. https://doi.org/10.1097/01.BRS.0000084267.41183.75 - DOI - PubMed

LinkOut - more resources